BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15231673)

  • 21. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
    J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer.
    Oshikiri T; Miyamoto M; Hiraoka K; Shichinohe T; Kawarada Y; Kato K; Suzuoki M; Nakakubo Y; Kondo S; Dosaka-Akita H; Kasahara N; Katoh H
    Cancer Gene Ther; 2006 Sep; 13(9):856-63. PubMed ID: 16710347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
    Shinoura N; Yoshida Y; Tsunoda R; Ohashi M; Zhang W; Asai A; Kirino T; Hamada H
    Cancer Res; 1999 Jul; 59(14):3411-6. PubMed ID: 10416603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY; Xia W; Shao R; Hung MC
    Oncogene; 1996 Oct; 13(7):1405-12. PubMed ID: 8875978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
    Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells.
    Robertson MW; Wang M; Siegal GP; Rosenfeld M; Ashford RS; Alvarez RD; Garver RI; Curiel DT
    Cancer Gene Ther; 1998; 5(5):331-6. PubMed ID: 9824053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by down-regulating Neu expression and preserving Rb function.
    Fang L; Huang Y; Hu X; Sun L; He X; Hu H; Pu Y; Cao X; Luo H; Pan S; Gu J; Su C
    Chem Biol Interact; 2009 Sep; 181(1):1-7. PubMed ID: 19523934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
    Fukazawa T; Maeda Y; Matsuoka J; Ono T; Mominoki K; Yamatsuji T; Shigemitsu K; Morita I; Murakami I; Tanaka H; Durbin ML; Naomoto Y
    Anticancer Res; 2010 Dec; 30(12):4925-35. PubMed ID: 21187472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
    Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
    Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma.
    Lee K; Yun ST; Yun CO; Ahn BY; Jo EC
    Gene Ther; 2012 Oct; 19(10):967-77. PubMed ID: 22033466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase-dependent oncolytic adenovirus for cancer treatment.
    Huang TG; Savontaus MJ; Shinozaki K; Sauter BV; Woo SL
    Gene Ther; 2003 Aug; 10(15):1241-7. PubMed ID: 12858189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.
    Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A
    Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CNHK200-hA-a gene-viral therapeutic system and its antitumor effect on lung cancer].
    Wang WG; Xue HB; Su CQ; Cui ZF; Nie MM; Sham J; Wu MC; Qian QJ
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):69-72. PubMed ID: 15946541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
    Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
    Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
    Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.